all - Opinion Summaries
Page 9 of 88
Showing Result 81 - 90 of 874
| Description | Date | Docket # |
|---|---|---|
Bristol-Myers Squibb Co. v. Superior CourtSupreme Court of California
Civil Procedure, Class Actions, Drugs & BiotechIn a civil procedure action, arising over patient injuries from taking Plavix, the Court of Appeal's judgment is affirmed where defendant's business... |
08/29/2016 | S221038 |
The Medicines Co. v. Hospira, Inc.United States Federal Circuit
Intellectual Property, Commercial Law, Patent, Drugs & BiotechIn a case arising from the submission of two Abbreviated New Drug Applications (ANDAs) for generic bivalirudin drug products before the expiration of... |
07/11/2016 | 14-1469 |
Amgen Inc. v. Apotex Inc.United States Federal Circuit
Intellectual Property, Patent, Drugs & BiotechIn an infringement suit brought under the Biologics Price Competition and Innovation Act of 2009 (BPCIA), involving a proposed biosimilar product to... |
07/05/2016 | 2016-1308 |
Rapid Litigation Management, Ltd. v. CellzDirect, Inc.United States Federal Circuit
Intellectual Property, Patent, Drugs & BiotechIn an infringement action involving a patent for an improved process of preserving hepatocytes, the District Court's summary judgment of invalidity... |
07/05/2016 | 2015-1570 |
Garcia v. Novartis PharmaceuticalsUnited States First Circuit
Injury & Tort Law, Drugs & BiotechIn qui tam actions under the False Claims Act (FCA), 31 U.S.C. section 3729 et seq., and related state statutes, alleging defendants caused physicians... |
06/17/2016 | 15-1470 |
Genzyme Therapeutic Prods. Ltd. P'ship v. Biomarin Pharm. Inc.United States Federal Circuit
Intellectual Property, Patent, Drugs & BiotechIn an appeal from decisions of the Patent Trial and Appeal Board in two inter partes review proceedings involving patents directed to treating Pompe's... |
06/14/2016 | 2015-1720, 2015-1721 |
Hochendoner v. Genzyme Corp.United States First Circuit
Civil Procedure, Drugs & BiotechIn consolidated actions arising out of the shortage of a medication that treats Fabry Disease, a rare genetic disorder that leaves afflicted persons... |
05/23/2016 | 15-1446, 15-1447 |
US ex rel. Polansky v. PfizerUnited States Second Circuit
Consumer Protection Law, False Advertising, Drugs & BiotechIn an action brought under the False Claims Act (FCA) and state analog causes of action against plaintiff's former employer, alleging it improperly... |
05/17/2016 | 14-4774 |
Intendis, GmbH v. Glenmark Pharms. Inc.United States Federal Circuit
Intellectual Property, Patent, Drugs & BiotechIn a case arising under the Hatch-Waxman Act involving a proposed generic version of Finacea Gel, a topical medication for various skin disorders, the... |
05/16/2016 | 2015-1902 |
Apotex Inc., et al., v. Acorda Therapeutics, Inc.United States Second Circuit
False Advertising, Drugs & Biotech, Antitrust & Trade RegulationIn a suit between rival manufacturers of tizanidine, a drug for treating spasticity, dealing with the circumstances under which the filing of a... |
05/16/2016 | 14-4353-cv |
Results 81 to 90 of 874